The Emerging Role of Amyloid PET Imaging in the Clinical Diagnosis and Management of Dementia

03/8/2013

Join SNMMI and the American Association for Geriatric Psychiatry for an informative session on the clinical use of amyloid PET imaging for dementia, March 16 from 2:45 to 4:15 pm at the JW Marriott in L.A. Live in Los Angeles. John Seibyl, MD, Peter Herscovitch, MD, and Norman Foster, MD, will update participants on the clinical implementation of recently approved PET radiotracers for detecting brain amyloid deposition. Onsite registration begins today, March 13.

View Full Article in:

http://www.aagponline.org/clientuploads/AAGP13%2520Final%2520program%25202-25%25...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI